Saikosaponin B1
APC-954
Saikosaponin B1
Cat. No.
APC-954
CAS No.
58558-08-0
MF
C42H68O13
MW
781
Saikosaponin B1 is a bioactive constituent of Radix Bupleuri. Saikosaponin B1 is an agonist of the 5-HT2C receptor, Saikosaponin B1 can be studies in research for cancers such as Medulloblastoma.
Technical Service Need help? Our team of experienced experts is here for you with full support.
86-28-85159085
info@aktin.com
Technical Data
Description
Storage and Shipping
References
Product Name
CAS No.
58558-08-0
MF
C42H68O13
MW
781
Specification
98%
Research Area
Anti-cancer, anti-inflammatory and hepatoprotective and choleretic
Description
Saikosaponin B1 is a bioactive constituent of Radix Bupleuri. Saikosaponin B1 is an agonist of the 5-HT2C receptor, Saikosaponin B1 can be studies in research for cancers such as Medulloblastoma. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g Availability: In stock
Documents
Certificate of Analysis (COA), Specification Sheet, HPLC, 1HNMR, 13CNMR, IR, MS, Safety Data Sheet (SDS/MSDS) etc.
Storage and Shipping
Store under frozen or refrigerated conditions, keep away from strong light and heat.
References
[1]. Luo J, et al., Saikosaponin B1 and Saikosaponin D inhibit tumor growth in medulloblastoma allograft mice via inhibiting the Hedgehog signaling pathway. J Nat Med. 2022 Jun;76(3):584-593.
[2]. Shao, M., et al., (2025), Saikosaponin b1 Attenuates Liver Fibrosis by Blocking STAT3/Gli1 Interaction and Inducing Gli1 Degradation. Exploration 270000.
[3]. Peng D, et L., Saikosaponin A and Its Epimers Alleviate LPS-Induced Acute Lung Injury in Mice. Molecules. 2023 Jan 18;28(3):967.
[4]. Sun, C. L., et al., (2017). Bioassay-guided isolation of saikosaponins with agonistic activity on 5-hydroxytryptamine 2C receptor from Bupleurum chinense and their potential use for the treatment of obesity. Chinese journal of natural medicines, 15(6), 467–473.
[2]. Shao, M., et al., (2025), Saikosaponin b1 Attenuates Liver Fibrosis by Blocking STAT3/Gli1 Interaction and Inducing Gli1 Degradation. Exploration 270000.
[3]. Peng D, et L., Saikosaponin A and Its Epimers Alleviate LPS-Induced Acute Lung Injury in Mice. Molecules. 2023 Jan 18;28(3):967.
[4]. Sun, C. L., et al., (2017). Bioassay-guided isolation of saikosaponins with agonistic activity on 5-hydroxytryptamine 2C receptor from Bupleurum chinense and their potential use for the treatment of obesity. Chinese journal of natural medicines, 15(6), 467–473.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
APC-1828
Eritadenine
CAS No.: 23918-98-1
MF: C9H11N5O4
APC-1827
Isobutyrylshikonin
CAS No.:52438-12-7
MF:C20H22O6
APC-1823
SO1861 (C28 sugar-chain positional isomer)
CAS No.:N/A
MF:C83H129O46
APC-1822
Bromocriptine mesylate
CAS No.:22260-51-1
MF:C32H40BrN5O5.CH4O3S
APC-1821
Cephaeline hydrochloride
CAS No.:3738-70-3
MF:C28H38N2O4.ClH
APC-1820
8-Feruloylharpagide
CAS No.:221003-20-9
MF:C25H32O13
APC-1819
6''-O-(p-coumaroyl)procumbide
CAS No.:87686-76-8
MF:C24H28O12
APC-1818
6′′-O-(p-Coumaroyl)harpagide
CAS No.:133561-42-9
MF:C24H30O12
APC-1817
Falcarinol
CAS No.:21852-80-2
MF:C17H24O
APC-1816
Dehydrotomatine
CAS No.:157604-98-3
MF:C50H81NO21
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
